Ceritinib/crizotinibDevelopment of resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1662卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33722-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：92 / 92

相关论文

共 50 条

[41] Alectinib/ceritinib/crizotinibAcquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2021, 1876 (1) : 21 - 21
[42] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2016, 1616 (1) : 15 - 15
[43] Ceritinib/crizotinibAcquired resistance to crizotinib, nausea, vomiting and increased transaminases: case report
Reactions Weekly, 2019, 1734 (1) : 123 - 123
[44] CrizotinibDevelopment of resistance during treatment for non-small cell lung cancer: case report
Reactions Weekly, 2017, 1666 (1) : 91 - 91
[45] CrizotinibDevelopment of acquired resistance due to acquired PIK3CA gene mutation: case report
Reactions Weekly, 2017, 1680 (1) : 101 - 101
[46] CrizotinibDevelopment of crizotinib resistance due to acquired ALK F1245C mutation: case report
Reactions Weekly, 2016, 1615 (1) : 72 - 72
[47] Brigatinib/crizotinibDevelopment of resistance to brigatinib and crizotinibin in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1780 (1) : 80 - 80
[48] Ceritinib/crizotinibEmergence of resistance, acute liver function lesion and severe diarrhoea: case report
Reactions Weekly, 2018, 1688 (1) : 55 - 55
[49] Alectinib/ceritinib/ensartinibLack of efficacy: case report
Reactions Weekly, 2024, 2038 (1) : 19 - 19
[50] Brigatinib/ceritinib/crizotinibLack of efficacy: case report
Reactions Weekly, 2023, 1943 (1) : 173 - 173

← 1 2 3 4 5 →